These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension. Park S, Chung N, Kwon J, Yoon JH, Kim YJ, Han DS, Kim HS. Clin Ther; 2005 Apr; 27(4):441-50. PubMed ID: 15922817 [Abstract] [Full Text] [Related]
12. Efficacy and tolerability of amlodipine in patients with mild-to-moderate hypertension. Olvera R, Samaniego V, Moguel R, Meaney E. Int J Clin Pharmacol Res; 1991 Apr; 11(5):237-41. PubMed ID: 1839988 [Abstract] [Full Text] [Related]
13. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension. Lorimer AR, Anderson JA, Laher MS, Davies J, Lazarus JH, Taylor SH, Sanghera S. J Hum Hypertens; 1994 Jan; 8(1):65-8. PubMed ID: 8151609 [Abstract] [Full Text] [Related]
14. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL. Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [Abstract] [Full Text] [Related]
16. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D. Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [Abstract] [Full Text] [Related]